Movement Alert | GENSCRIPT BIO Rises 4.62% in Regular Trading, Joint NVIDIA PitchFest to Expand AIDD Wet-Lab Demand

Market Focus

Yesterday

On October 12, GENSCRIPT BIO rose 4.62% in regular trading, trading at HK$44.18/share, with Turnover of HK$70.3159 million.

The move followed the launch of a global life sciences startup PitchFest competition jointly held by GENSCRIPT BIO and NVIDIA, targeting startups applying AI to therapeutic discovery and life sciences. The initiative combines GENSCRIPT BIO's wet-lab validation and data generation capabilities with NVIDIA's accelerated computing platform and startup ecosystem resources.

The market viewed the collaboration as expanding the scope of the company's wet-lab services and accelerating AIDD-related business development. This came after the company announced a partnership with Eli Lilly's AIDD collaboration platform Lilly TuneLab, which J.P. Morgan characterized as a strategic entry into an ecosystem of more than 100 biotech clients.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://nz.tigrwd.com/news/1180779511"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1180779511\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1180779511?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-12 09:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180779511","market":"hk","top_or_hot":-1,"title":"Movement Alert | GENSCRIPT BIO Rises 4.62% in Regular Trading, Joint NVIDIA PitchFest to Expand AIDD Wet-Lab Demand","media":"Market Focus","content":"<p><p>On October 12, GENSCRIPT BIO rose 4.62% in regular trading, trading at HK$44.18/share, with Turnover of HK$70.3159 million.</p><p>The move followed the launch of a global life sciences startup PitchFest competition jointly held by GENSCRIPT BIO and NVIDIA, targeting startups applying AI to therapeutic discovery and life sciences. The initiative combines GENSCRIPT BIO's wet-lab validation and data generation capabilities with NVIDIA's accelerated computing platform and startup ecosystem resources.</p><p>The market viewed the collaboration as expanding the scope of the company's wet-lab services and accelerating AIDD-related business development. This came after the company announced a partnership with Eli Lilly's AIDD collaboration platform Lilly TuneLab, which J.P. Morgan characterized as a strategic entry into an ecosystem of more than 100 biotech clients.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert | GENSCRIPT BIO Rises 4.62% in Regular Trading, Joint NVIDIA PitchFest to Expand AIDD Wet-Lab Demand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert | GENSCRIPT BIO Rises 4.62% in Regular Trading, Joint NVIDIA PitchFest to Expand AIDD Wet-Lab Demand\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-12 09:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 12, GENSCRIPT BIO rose 4.62% in regular trading, trading at HK$44.18/share, with Turnover of HK$70.3159 million.</p><p>The move followed the launch of a global life sciences startup PitchFest competition jointly held by GENSCRIPT BIO and NVIDIA, targeting startups applying AI to therapeutic discovery and life sciences. The initiative combines GENSCRIPT BIO's wet-lab validation and data generation capabilities with NVIDIA's accelerated computing platform and startup ecosystem resources.</p><p>The market viewed the collaboration as expanding the scope of the company's wet-lab services and accelerating AIDD-related business development. This came after the company announced a partnership with Eli Lilly's AIDD collaboration platform Lilly TuneLab, which J.P. Morgan characterized as a strategic entry into an ecosystem of more than 100 biotech clients.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01548","symbol_name":"金斯瑞生物科技","start_time":0,"source_url":"","article_id":"1180779511","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180779511","pubTimestamp":1791768682,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 12, GENSCRIPT BIO rose 4.62% in regular trading, trading at HK$44.18/share, with Turnover of HK$70.3159 million.The move followed the launch of a global life sciences startup PitchFest...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01548":"金斯瑞生物科技"},"translate_title":"走势警报 | 金斯瑞生物常规交易上涨 4.62%，联合英伟达 PitchFest 扩大 AIDD 湿实验室需求","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01548":1},"content_text":"On October 12, GENSCRIPT BIO rose 4.62% in regular trading, trading at HK$44.18/share, with Turnover of HK$70.3159 million.The move followed the launch of a global life sciences startup PitchFest competition jointly held by GENSCRIPT BIO and NVIDIA, targeting startups applying AI to therapeutic discovery and life sciences. The initiative combines GENSCRIPT BIO's wet-lab validation and data generation capabilities with NVIDIA's accelerated computing platform and startup ecosystem resources.The market viewed the collaboration as expanding the scope of the company's wet-lab services and accelerating AIDD-related business development. This came after the company announced a partnership with Eli Lilly's AIDD collaboration platform Lilly TuneLab, which J.P. Morgan characterized as a strategic entry into an ecosystem of more than 100 biotech clients.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}